| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/11/1997 | US5610185 Method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds |
| 03/11/1997 | US5610183 Phenylglycine derivatives pharmaceutical compositions containing them and their use in therapy |
| 03/11/1997 | US5610175 9-Substituted porphycenes |
| 03/11/1997 | US5610167 Methods of inhibiting atrophy of the skin and vagina |
| 03/11/1997 | US5610146 2,3-disubstituted isoxazolidines, a process for their preparation, agents containing them, and their use |
| 03/11/1997 | US5609873 Treatment of psoriasis and other skin disorders associated with keratinocyte differentiation |
| 03/11/1997 | US5609853 Photoprotective/cosmetic compositions comprising synergistic admixture of sunscreen compounds |
| 03/07/1997 | CA2184881A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity prepared therefrom |
| 03/06/1997 | WO1997008311A1 Novel procollagens |
| 03/06/1997 | WO1997007772A1 Compositions containing a peptide cell growth promoter |
| 03/05/1997 | EP0759783A1 Anti-inflammatory wound healing compositions and methods for preparing and using same |
| 03/05/1997 | EP0759765A1 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
| 03/05/1997 | EP0759760A1 Wound healing agent |
| 03/05/1997 | EP0759752A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 03/05/1997 | EP0759749A1 Anti-acne compositions |
| 03/05/1997 | EP0759740A1 Use of laminarin and oligosaccharides derived therefrom in cosmetics and for preparing a skin treatment drug |
| 03/05/1997 | EP0623122B1 Benzopyran and related LTB4-antagonists. |
| 03/05/1997 | CN1144128A Pure traditional Chinese medicinal liquor with antisenile action |
| 03/05/1997 | CN1144091A Compounds having retinoid-like activity |
| 03/04/1997 | US5608093 Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters, and pharmaceuticals containing these compounds |
| 03/04/1997 | US5607980 Topical compositions having improved skin feel |
| 03/04/1997 | US5607944 Bicyclic heterocyclic compounds, pharmaceutical preparations containing these compounds and processes for their preparations |
| 03/04/1997 | US5607921 Stabilized cosmetic or dermatological composition containing several precursors of the same active agent in order to maximize its release, and use thereof |
| 03/04/1997 | US5607699 Non-aqueous emiollient iodophor formulations |
| 03/04/1997 | US5607694 Forming sealant by mixing virus inactivated fibrinogen and thrombin, liposomes with entrapped medicaments deliverable in wound or opening, and calcium; thrombin promotes fibrin clot formation, liposomes release medicaments |
| 02/27/1997 | WO1997007232A1 Antigenic preparations |
| 02/27/1997 | WO1997007214A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 02/27/1997 | WO1997007136A2 Pharmaceutical composition containing inhibitors of interferon-gamma |
| 02/27/1997 | WO1997006814A1 Method of promoting angiogenesis |
| 02/27/1997 | WO1997006659A2 Use of an eriobotrya japonica extract |
| 02/27/1997 | CA2614655A1 Pharmaceutical composition containing inhibitors of interferon-gamma |
| 02/26/1997 | EP0759469A1 Bacteriocin |
| 02/26/1997 | EP0759070A1 Blood-borne mesenchymal cells |
| 02/26/1997 | EP0758882A1 Methods of lightening hyperpigmented regions in mammalian skin |
| 02/26/1997 | EP0758879A1 Improved anti-dandruff shampoo |
| 02/26/1997 | EP0726911A4 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
| 02/26/1997 | EP0587819B1 Medetomidine preparations for transdermal administration |
| 02/26/1997 | CN1143949A Method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of complexes |
| 02/26/1997 | CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r |
| 02/26/1997 | CN1143495A Ointment for eliminating tinea |
| 02/26/1997 | CN1143494A Composition for resisting skin spots or senility and use thereof |
| 02/25/1997 | US5606047 Includes polynucleotide duplexes that have significant binding activity for lupus antibodies |
| 02/25/1997 | US5606032 Extraction of vertebrate brain material to obtain protein; chromatographic purification |
| 02/25/1997 | US5605938 Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| 02/25/1997 | US5605933 Retinoid conjugate compounds and methods for treating of skin aging |
| 02/25/1997 | US5605930 Compositions and methods for treating and preventing pathologies including cancer |
| 02/25/1997 | US5605929 Methods and compositions for inhibiting 5α-reductase activity |
| 02/25/1997 | US5605902 5-HT2 receptor antagonist compositions useful in treating venous conditions |
| 02/25/1997 | US5605894 Compositions for regulating skin wrinkles and/or skin atrophy |
| 02/25/1997 | US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites |
| 02/25/1997 | US5605700 Topical administration of toremifene and its metabolites |
| 02/25/1997 | CA2077991C Cosmetics and pharmaceuticals containing extensins and related methods |
| 02/25/1997 | CA1338939C Vinylphenol derivatives, their preparation and their use |
| 02/20/1997 | WO1997006242A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | WO1997005894A1 Pharmaceutical composition containing il-10 |
| 02/20/1997 | WO1997005892A1 Use of betaglycan to reduce scarring |
| 02/20/1997 | WO1997005883A1 Pharmaceutical composition |
| 02/20/1997 | WO1997005865A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen |
| 02/20/1997 | CA2229098A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen |
| 02/20/1997 | CA2229044A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | CA2228650A1 Use of betaglycan to reduce scarring |
| 02/20/1997 | CA2213773A1 Imidazopyridine derivatives |
| 02/19/1997 | EP0758243A1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWISa |
| 02/19/1997 | EP0758239A1 Use of xanthine derivatives for reducing the pathological hyper-reactivity of eosinophilic granulocytes, novel xanthine compounds and process for producing them |
| 02/19/1997 | EP0758238A1 Spiro-substituted azacycles as neurokinin-3 antagonists |
| 02/19/1997 | EP0654026B1 Isoserine derivatives and their use as leukotriene antagonists |
| 02/19/1997 | CN1143366A 4-amino derivatives of mycophenolic acid |
| 02/19/1997 | CN1143363A Isoxazoline compounds as inhibitors of TNF release |
| 02/19/1997 | CN1143356A Process for isomerizing linear olefins to isoolefins |
| 02/19/1997 | CN1143324A Novel pharmaceutical composition for skin diseases |
| 02/19/1997 | CN1143319A Compound and methods for treatment of cardiovascular, inflammatory and immune disorders |
| 02/18/1997 | US5604262 Topical antimicrobial agents |
| 02/18/1997 | US5604212 Salicylic acid for regulating skin wrinkles and/or skin atrophy |
| 02/13/1997 | WO1997005250A2 Receptor ligand vegf-c |
| 02/13/1997 | WO1997005127A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 02/13/1997 | WO1997004807A1 Methods for treatment of allergic asthma |
| 02/13/1997 | WO1997004788A2 Use of calendula glycosides for the treatment of psoriasis |
| 02/13/1997 | WO1997004779A1 Quinolones and their therapeutic use |
| 02/13/1997 | WO1997004768A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | WO1997004767A1 Hydroxyl radical scavenger |
| 02/13/1997 | WO1997004765A1 INHIBITION OF CoA-INDEPENDENT TRANSACYLASE AND APOPTOSIS |
| 02/13/1997 | WO1997004720A1 The use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| 02/13/1997 | CA2228298A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | CA2228248A1 Receptor ligand vegf-c |
| 02/13/1997 | CA2227808A1 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases |
| 02/13/1997 | CA2227751A1 Use of calendula glycosides for the treatment of psoriasis |
| 02/13/1997 | CA2226624A1 Methods for treatment of allergic asthma |
| 02/13/1997 | CA2225552A1 Quinolones and their therapeutic use |
| 02/12/1997 | EP0757717A1 Papillomavirus vaccines |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142832A CS-1 peptidomimetics, compositions and methods of using the same |
| 02/12/1997 | CN1142499A Tricyclic 5,6-dihydro-9H-pyrazolo|3,4-c¨-1,2,4,-triaolo (4,3-alpha¨ pyridines |
| 02/12/1997 | CN1142496A New thiophene compounds, process for their preparation and pharmaceutical compositions containing them |
| 02/12/1997 | CN1142387A Chinese medicine paste "Pifubadugao' for dermatosis |
| 02/11/1997 | US5602253 Peptides derivatives |
| 02/11/1997 | US5602176 Phenyl carbamate |
| 02/11/1997 | US5602152 Benzoxepines |
| 02/11/1997 | US5602104 Skin disorders, conjunctive tissue disorders, antitumor agents |
| 02/11/1997 | US5602096 Contacting cell with glial growth factor |
| 02/11/1997 | CA2034546C 1, 3-dicarbonyl compounds and their use |